Meta-analysis: Prognostic Value of Survivin in Patients with Pancreatic Cancer

Jinlong Liu,Xuejun Zhang,Shuguang Yang,Zhao Zhang,Qiuju Yue,Xiaodong Liu

2014-01-01

Abstract:Objective: The aim of the study was to conduct a systematic review of the literature evaluating survivin expres- sion in pancreatic carcinoma as a prognostic indicator. Methods: The relevant literatures were searched using PubMed, EMBASE, and Chinese Biomedicine Databases. A meta-analysis of the association between survivin expression and overall survival in patients with pancreatic cancer was performed. Studies were pooled and summary hazard ratios (HRs) were calcu- lated. Subgroup analysis according to the location of survivin expression was also performed. Results: Seven eligible studies with a total of 448 patients were included in this study. Combined HR suggested that survivin expression had an unfavorable impact on survival of pancreatic cancer patients (HR = 1.65, 95% CI: 1.02-2.68). When stratified according to the location of survivin expression, the combined HR showed that expression in the cytoplasm was significantly associated with poor prog- nosis of pancreatic cancer patients (HR = 2.09, 95% CI: 1.29-3.40). In contrast, survivin expression in the nucleus was not significantly associated with poor prognosis (HR = 0.83, 95% CI: 0.24-2.81), and the heterogeneity was highly significant (I 2 = 87.2%, P = 0.005). Conclusion: Survivin expression was associated with a poor prognosis in patients with pancreatic cancer. Cytoplasmic expression of survivin may be a prognostic factor for pancreatic cancer patients. Based on the current obtained data, there was no evidence that survivin expression in the nucleus had a significant impact on patients' overall survival.